Halo U: FMM 201 and SMI 301: Subvisible Particle Identification using Side-Illumination and Fluorescence Membrane Microscopy on Protein Therapeutic Formulations
Subvisible particles are a critical quality attribute (CQA) for protein therapeutics that can limit a product’s shelf-life and induce immunogenicity.…
Read MoreTech Note 5: SIMI: A Different Approach to Revealing Dangerous Subvisible Impurities
Please fill out the form to download the tech note.
Read MoreParticle Vue 21 CFR Part 11 Documentation
Download PDF
Read MoreGEN Webinar – High Throughput Low Volume Subvisible Analysis – February 2018
Watch the latest GEN webinar where we will learn how a new particle analysis instrument called HORIZON employs backgrounded membrane…
Read MoreSeeking The Unseen: Sub-visible Particle Analysis As A Core Analytical Technique
In this webinar, Fujifilm Diosynth Biotechnologies presents comparative analytical data spanning across several different research programs then present a more…
Read MoreVirtual Seminar – AAV Vector Stability With BMI – Are Your Analytics Giving You The Whole Picture? – April 2020
Subvisible particle (SVP) analysis in parenteral formulations is a key predictor of safety and efficacy, and an essential drug quality…
Read MoreBiopharm Intl Webinar – Are You Seeing The Whole Picture?
In this webinar, we introduce how Backgrounded Membrane Imaging (BMI) can be used to analyze subvisible particles (SVP), an indicator…
Read MoreBMI Count And Size Validation With Aura
The Aura™ system, with its ability to count, size, and ID particles, is a powerful tool for biologics and gene…
Read MoreAura: Particle And Aggregate Quantification, Characterization, ID, And Full USP <788> Testing
Learn how the Aura system can be a complete tool for your lab’s stability testing and quality control measurements. With…
Read MoreCell Line Development: Identifying Stable Biologic Candidates
Cell line development (CLD) is a critical aspect of the drug discovery process, and nowhere is this more apparent than…
Read More
